Avantor, Inc. (NYSE:AVTR) Receives Average Recommendation of “Moderate Buy” from Brokerages

Avantor, Inc. (NYSE:AVTR) has earned an average rating of “Moderate Buy” from the fourteen analysts that are presently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $27.69.

Several equities research analysts recently weighed in on the company. Wells Fargo & Company reduced their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Robert W. Baird reduced their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Barclays lowered their target price on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday, October 25th. UBS Group cut their target price on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research report on Tuesday, October 8th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $34.00 price target on shares of Avantor in a research report on Thursday, September 26th.

Avantor Price Performance

Shares of NYSE:AVTR opened at $21.39 on Friday. The stock has a market capitalization of $14.56 billion, a P/E ratio of 46.50, a P/E/G ratio of 2.57 and a beta of 1.29. The business has a 50-day moving average of $22.78 and a two-hundred day moving average of $23.59. Avantor has a fifty-two week low of $19.59 and a fifty-two week high of $28.00. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06.

Institutional Investors Weigh In On Avantor

Institutional investors and hedge funds have recently bought and sold shares of the business. Versant Capital Management Inc increased its stake in Avantor by 2,003.6% in the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after acquiring an additional 1,102 shares during the period. Blue Trust Inc. boosted its holdings in Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after purchasing an additional 1,391 shares in the last quarter. UMB Bank n.a. bought a new stake in shares of Avantor in the 3rd quarter valued at approximately $49,000. Nisa Investment Advisors LLC raised its holdings in shares of Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after buying an additional 835 shares in the last quarter. Finally, GAMMA Investing LLC lifted its position in shares of Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after buying an additional 1,285 shares during the period. Institutional investors own 95.08% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.